|
|
|
|||||||
|
|||||||||
J. Biol. Chem., Vol. 277, Issue 4, 2695-2701, January 25, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the The transcription factor RUNX2
(Cbfa1/AML3/Pebp2
Expression of the Osteoblast Differentiation Factor RUNX2
(Cbfa1/AML3/Pebp2
A) Is Inhibited by Tumor Necrosis
Factor-*
,,,,¶
Division of Endocrinology and Metabolism,
Emory University School of Medicine and Atlanta Veterans Affairs
Medical Center, Atlanta, Georgia 30033 and the § Department
of Cell Biology, University of Massachusetts Medical School,
Worcester, Massachusetts 01655
A) is a critical regulator of osteoblast
differentiation. We investigated the effect of the inflammatory
cytokine tumor necrosis factor (TNF) on the expression of RUNX2
because TNF is known to inhibit differentiation of osteoblasts from
pluripotent progenitor cells. TNF treatment of fetal calvaria precursor
cells or MC3T3-E1 clonal pre-osteoblastic cells caused a
dose-dependent suppression of RUNX2 steady state mRNA
as measured by reverse transcription-PCR. The IC50
for TNF inhibition was 0.6 ng/ml. TNF suppression of RUNX2 mRNA was
confirmed using Northern analysis. The effect of TNF was studied using
isoform-specific primers that flanked unique regions of two major RUNX2
isoforms. TNF suppressed expression of the mRNA coding for the
shorter MRIPV isoform by >90% while inhibiting expression of the
mRNA for the longer MASNS isoform by 50%. RUNX2 nuclear content
was evaluated by electrophoretic mobility shift assay using a rat
osteocalcin promoter binding sequence as probe and by Western analysis.
TNF reduced nuclear RUNX2 protein. Inhibition of new protein synthesis
with cycloheximide failed to prevent TNF inhibition of RUNX2 mRNA,
suggesting that a newly translated protein did not mediate the TNF
effect. RUNX2 mRNA half-life was 1.8 h and reduced to 0.9 h by TNF. The effect of TNF on RUNX2 gene transcription was evaluated
using a 0.6-kb RUNX2 promoter-luciferase reporter in MC3T3-E1 cells.
TNF caused a dose-dependent inhibition of transcription to
50% of control values. The inhibitory effect of TNF was preserved with
deletions to nucleotide 
108 upstream of the translational start site;
however, localization downstream of nucleotide 108 was obscured by
loss of basal activity. Our results indicate that TNF regulates RUNX2 expression at multiple levels including destabilization of mRNA and
suppression of transcription. The disproportionate inhibition of RUNX2
nuclear protein suggests that additional post-transcriptional mechanisms may be occurring. Suppression of RUNX2 by TNF may decrease osteoblast differentiation and inhibit bone formation in TNF excess states.
*
This work was supported by National Institutes of Health
Grant R01 AR46452-01 and a Department of Veterans Affairs Merit Review grant (both to M. S. N.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Morimoto, S. Kuroda, T. Kizawa, K. Nomura, C. Higuchi, H. Yoshikawa, and T. Tomita Equivalent osteoblastic differentiation function of human mesenchymal stem cells from rheumatoid arthritis in comparison with osteoarthritis Rheumatology, June 1, 2009; 48(6): 643 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Harris, P. Senagore, V. B. Young, and L. R. McCabe Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice Am J Physiol Gastrointest Liver Physiol, May 1, 2009; 296(5): G1020 - G1029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Guo, M. Yamashita, Q. Zhang, Q. Zhou, D. Chen, D. G. Reynolds, H. A. Awad, L. Yanoso, L. Zhao, E. M. Schwarz, et al. Ubiquitin Ligase Smurf1 Mediates Tumor Necrosis Factor-induced Systemic Bone Loss by Promoting Proteasomal Degradation of Bone Morphogenetic Signaling Proteins J. Biol. Chem., August 22, 2008; 283(34): 23084 - 23092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hewitt, X. Lu, L. Gilbert, and M. S. Nanes The Muscle Transcription Factor MyoD Promotes Osteoblast Differentiation by Stimulation of the Osterix Promoter Endocrinology, July 1, 2008; 149(7): 3698 - 3707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yu, Y. Jiang, D. L. Galson, M. Luo, Y. Lai, Y. Lu, H.-J. Ouyang, J. Zhang, and G. Xiao General Transcription Factor IIA-{gamma} Increases Osteoblast-specific Osteocalcin Gene Expression via Activating Transcription Factor 4 and Runt-related Transcription Factor 2 J. Biol. Chem., February 29, 2008; 283(9): 5542 - 5553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Manton, D. F. M. Leong, S. M. Cool, and V. Nurcombe Disruption of Heparan and Chondroitin Sulfate Signaling Enhances Mesenchymal Stem Cell-Derived Osteogenic Differentiation via Bone Morphogenetic Protein Signaling Pathways Stem Cells, November 1, 2007; 25(11): 2845 - 2854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Baraliakos, J. Listing, J. Brandt, H. Haibel, M. Rudwaleit, J. Sieper, and J. Braun Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-{alpha} antibody infliximab Rheumatology, September 1, 2007; 46(9): 1450 - 1453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.-H. Tang, P. Xiao, S.-F. Lei, F.-Y. Deng, L.-J. Zhao, H.-Y. Deng, L.-J. Tan, H. Shen, D.-H. Xiong, R. R. Recker, et al. A Bivariate Whole-Genome Linkage Scan Suggests Several Shared Genomic Regions for Obesity and Osteoporosis J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2751 - 2757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Leonard Glucocorticoid-Induced Osteoporosis in Children: Impact of the Underlying Disease Pediatrics, March 1, 2007; 119(Supplement_2): S166 - S174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Lu, L. Gilbert, X. He, J. Rubin, and M. S. Nanes Transcriptional Regulation of the Osterix (Osx, Sp7) Promoter by Tumor Necrosis Factor Identifies Disparate Effects of Mitogen-activated Protein Kinase and NF{kappa}B Pathways J. Biol. Chem., March 10, 2006; 281(10): 6297 - 6306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kaneki, R. Guo, D. Chen, Z. Yao, E. M. Schwarz, Y. E. Zhang, B. F. Boyce, and L. Xing Tumor Necrosis Factor Promotes Runx2 Degradation through Up-regulation of Smurf1 and Smurf2 in Osteoblasts J. Biol. Chem., February 17, 2006; 281(7): 4326 - 4333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Frick, K. LaPlante, and D. A. Bushinsky RANK ligand and TNF-{alpha} mediate acid-induced bone calcium efflux in vitro Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1005 - F1011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Xiao, D. Jiang, C. Ge, Z. Zhao, Y. Lai, H. Boules, M. Phimphilai, X. Yang, G. Karsenty, and R. T. Franceschi Cooperative Interactions between Activating Transcription Factor 4 and Runx2/Cbfa1 Stimulate Osteoblast-specific Osteocalcin Gene Expression J. Biol. Chem., September 2, 2005; 280(35): 30689 - 30696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Gilbert, J. Rubin, and M. S. Nanes The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E1011 - E1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Jagger, J. M. Lean, J. T. Davies, and T. J. Chambers Tumor Necrosis Factor-{alpha} Mediates Osteopenia Caused by Depletion of Antioxidants Endocrinology, January 1, 2005; 146(1): 113 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Qiao, P. Shapiro, R. Kumar, and A. Passaniti Insulin-like Growth Factor-1 Regulates Endogenous RUNX2 Activity in Endothelial Cells through a Phosphatidylinositol 3-Kinase/ERK-dependent and Akt-independent Signaling Pathway J. Biol. Chem., October 8, 2004; 279(41): 42709 - 42718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nakamoto, A. Shiratsuchi, H. Oda, K. Inoue, T. Matsumura, M. Ichikawa, T. Saito, S. Seo, K. Maki, T. Asai, et al. Impaired spermatogenesis and male fertility defects in CIZ/Nmp4-disrupted mice Genes Cells, June 1, 2004; 9(6): 575 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-S. Xiao, A. B. Hjelmeland, and L. D. Quarles Selective Deficiency of the "Bone-related" Runx2-II Unexpectedly Preserves Osteoblast-mediated Skeletogenesis J. Biol. Chem., May 7, 2004; 279(19): 20307 - 20313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Jiang, R. T. Franceschi, H. Boules, and G. Xiao Parathyroid Hormone Induction of the Osteocalcin Gene: REQUIREMENT FOR AN OSTEOBLAST-SPECIFIC ELEMENT 1 SEQUENCE IN THE PROMOTER AND INVOLVEMENT OF MULTIPLE SIGNALING PATHWAYS J. Biol. Chem., February 13, 2004; 279(7): 5329 - 5337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Redlich, B. Gortz, S. Hayer, J. Zwerina, N. Doerr, P. Kostenuik, H. Bergmeister, G. Kollias, G. Steiner, J. S. Smolen, et al. Repair of Local Bone Erosions and Reversal of Systemic Bone Loss Upon Therapy with Anti-Tumor Necrosis Factor in Combination with Osteoprotegerin or Parathyroid Hormone in Tumor Necrosis Factor-Mediated Arthritis Am. J. Pathol., February 1, 2004; 164(2): 543 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sitcheran, P. C. Cogswell, and A. S. Baldwin Jr. NF-{kappa}B mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism Genes & Dev., October 1, 2003; 17(19): 2368 - 2373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Marzo-Ortega, D McGonagle, G Haugeberg, M J Green, S P Stewart, and P Emery Bone mineral density improvement in spondyloarthropathy after treatment with etanercept Ann Rheum Dis, October 1, 2003; 62(10): 1020 - 1021. [Full Text]
|
|
|
|
 |
|
 J. Pratap, M. Galindo, S. K. Zaidi, D. Vradii, B. M. Bhat, J. A. Robinson, J.-Y. Choi, T. Komori, J. L. Stein, J. B. Lian, et al. Cell Growth Regulatory Role of Runx2 during Proliferative Expansion of Preosteoblasts Cancer Res., September 1, 2003; 63(17): 5357 - 5362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kahler and J. J. Westendorf Lymphoid Enhancer Factor-1 and beta -Catenin Inhibit Runx2-dependent Transcriptional Activation of the Osteocalcin Promoter J. Biol. Chem., March 28, 2003; 278(14): 11937 - 11944. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |